BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28050764)

  • 1. Polymorphisms in apoptosis-related genes in cutaneous melanoma prognosis: sex disparity.
    Oliveira C; Lourenço GJ; Rinck-Junior JA; de Moraes AM; Lima CS
    Med Oncol; 2017 Feb; 34(2):19. PubMed ID: 28050764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between genetic polymorphisms in apoptosis-related genes and risk of cutaneous melanoma in women and men.
    Oliveira C; Lourenço GJ; Rinck-Junior JA; Cintra ML; Moraes AM; Lima CS
    J Dermatol Sci; 2014 May; 74(2):135-41. PubMed ID: 24461648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro), and GSTP1 (Ile105Val) polymorphisms in prognosis of cutaneous melanoma.
    Gomez GV; de Oliveira C; Rinck-Junior JA; de Moraes AM; Lourenço GJ; Lima CS
    Tumour Biol; 2016 Mar; 37(3):3163-71. PubMed ID: 26427666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the effect of MDM2 SNP309 and TP53 Arg72Pro polymorphisms on the age of onset of cutaneous melanoma.
    Cotignola J; Chou JF; Roy P; Mitra N; Busam K; Halpern AC; Orlow I
    J Invest Dermatol; 2012 May; 132(5):1471-8. PubMed ID: 22336942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of IL1B (rs16944) and IL1R2 (rs4141134) polymorphisms on aggressiveness and prognosis of cutaneous melanoma.
    Torricelli C; Carron J; Carvalho BF; Macedo LT; Rinck-Junior JA; Lima CSP; Lourenço GJ
    Melanoma Res; 2021 Oct; 31(5):476-481. PubMed ID: 34284461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro) and GSTP1 (Ile105Val) polymorphisms in the risk of cutaneous melanoma.
    Oliveira C; Rinck-Junior JA; Lourenço GJ; Moraes AM; Lima CS
    J Cancer Res Clin Oncol; 2013 Jul; 139(7):1199-206. PubMed ID: 23568549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.
    Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Meka P; Annamaneni S; Digumarthi R; Sinha S; Satti V
    Tumour Biol; 2015 Sep; 36(10):7967-76. PubMed ID: 25957891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.
    van den Broek AJ; Broeks A; Horlings HM; Canisius SV; Braaf LM; Langerød A; Van't Veer LJ; Schmidt MK
    Breast Cancer Res Treat; 2011 Nov; 130(2):599-608. PubMed ID: 21667122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of BCL2 and BAX Genes Associate with Outcomes in Advanced Non-small cell lung cancer Patients treated with platinum-based Chemotherapy.
    Peng Y; Wang L; Qing Y; Li C; Ren T; Li Q; Li M; Zhang S; Shan J; Wang G; Yang Z; Wang D
    Sci Rep; 2015 Dec; 5():17766. PubMed ID: 26656462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
    Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
    Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients.
    Figl A; Scherer D; Nagore E; Bermejo JL; Dickes E; Thirumaran RK; Gast A; Hemminki K; Kumar R; Schadendorf D
    Mutat Res; 2009 Feb; 661(1-2):78-84. PubMed ID: 19073198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic association of the polymorphisms in apoptosis-related genes with osteoarthritis susceptibility in Chinese Han population.
    Ma G; Jiang D; Huang J
    Int J Clin Exp Pathol; 2018; 11(4):2221-2226. PubMed ID: 31938334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2 SNP309 promoter polymorphism confers risk for hereditary melanoma.
    Thunell LK; Bivik C; Wäster P; Fredrikson M; Stjernström A; Synnerstad I; Rosdahl I; Enerbäck C
    Melanoma Res; 2014 Jun; 24(3):190-7. PubMed ID: 24625390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.
    Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D
    Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDCD1 gene polymorphisms as regulators of T-lymphocyte activity in cutaneous melanoma risk and prognosis.
    Gomez GVB; Rinck-Junior JA; Oliveira C; Silva DHL; Mamoni RL; Lourenço GJ; Moraes AM; Lima CSP
    Pigment Cell Melanoma Res; 2018 Mar; 31(2):308-317. PubMed ID: 29090522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited variations in human pigmentation-related genes modulate cutaneous melanoma risk and clinicopathological features in Brazilian population.
    Lourenço GJ; Oliveira C; Carvalho BS; Torricelli C; Silva JK; Gomez GVB; Rinck-Junior JA; Oliveira WL; Vazquez VL; Serrano SV; Moraes AM; Lima CSP
    Sci Rep; 2020 Jul; 10(1):12129. PubMed ID: 32699307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
    Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
    Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
    Wang ML; Xu YX; Qian J; Wang FH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival.
    Xu Y; Wang Y; Liu H; Shi Q; Zhu D; Amos CI; Fang S; Lee JE; Hyslop T; Li X; Han J; Wei Q
    Mol Carcinog; 2018 Jan; 57(1):22-31. PubMed ID: 28796414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.